Table 5

Quantification of strength of COVID-19 treatment guidelines according to region and disease severity using an adapted metric based upon the July 2022 WHO guideline11

RegionTherapeutic indication for non-severe disease
Range: −14 to 21
Therapeutic indication for severe disease
Range: −12 to 14
AFR−2.2 (±5.8)2.8 (±6.0)
AMR1.3 (±8.1)7.4 (±6.9)
SEAR6.3 (±7.0)7.4 (±3.7)
EUR8.1 (±6.8)8.1 (±4.3)
EMR0.82 (±3.4)3.5 (±6.6)
WPR7.25 (±10.3)5.8 (±4.8)
  • Data are presented as mean (±SD).

  • AFR, African Region; AMR, Region of the Americas; EMR, Eastern Mediterranean Region; EUR, European Region; SEAR, South-East Asian Region; WPR, Western Pacific Region.